A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”.
The experimental drug - named Lecanemab - showed the promising effects in a trial that spanned 18 months and involved nearly 1,800 patients with early-stage Alzheimer’s.
